Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

625.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 1,545.00
  • 52 Week Low: 130.00
  • Currency: UK Pounds
  • Shares Issued: 6.04m
  • Volume: 8,230
  • Market Cap: £37.76m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,173,294
Vladislav Sandler Ph.D. 103,862 £649,138
Peter Redmond 13,991 £87,444

Major Shareholders

Notifier** Holding Value*
David John Smith 468,923 £2,930,769
Alexis Sandler 187,726 £1,173,288
Dr Vladislav Sandler 103,862 £649,138
Optiva Securities Limited 70,329 £439,556
Flascherberg Capital Anstalt 69,991 £437,444
Craig Auringer 59,593 £372,456
HSBC Client Holdings Nominee (UK) Limited 45,160 £282,250
Ron Valk 42,828 £267,675
Samantha Bauer 42,706 £266,912
Plum Capital 29,232 £182,700
43 North LLC 28,429 £177,681
Abdelatif LACHAB 6,500 £40,625
Wayne Gibson 6,500 £40,625

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 625.00p
Change Today -2.00p
% Change -0.32 %
52 Week High 1,545.00
52 Week Low 130.00
Volume 8,230
Shares Issued 6.04m
Market Cap £37.76m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 16-Jan-2026

Time Volume / Share Price
16:26 1 @ 642.00p
16:22 1 @ 642.00p
16:22 200 @ 623.28p
16:15 250 @ 623.26p
15:58 959 @ 621.60p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page